Yes Pete , info that was not asked for, seemed like a bit of a smoke screen or a look over there nothing going on here comment.
A very loud no comment as to weather or not Dr Susan Mathers or Prof Dominic Rowe have had or will have any input to the clinical studies.
By the way both are involved in clinical studies, both are familiar with MPL and both specialise in Neurological Diseases. Just an obversion.
IMO at this stage of the game MT and his team would not be asking questions about MPL that they do not have a pretty good idea what the answers will be.
Block buster indeed
Good luck to all.
Ann: PharmAust to present at NWR Virtual Healthcare Conference, page-88
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $95.88M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $24.88K | 124.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6557 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 106840 | 6 |
View Market Depth
| Last trade - 11.23am 18/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |